[HTML][HTML] Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
A Stanley, GH Ashrafi, AM Seddon, H Modjtahedi - Scientific Reports, 2017 - nature.com
Overexpression of HER2 has been reported in around 25% of human breast cancers.
Despite recent advances in HER2 targeted therapy, many patients still experience primary …
Despite recent advances in HER2 targeted therapy, many patients still experience primary …
Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines.
A Stanley, GH Ashrafi, AM Seddon… - Scientific Reports, 2017 - europepmc.org
Overexpression of HER2 has been reported in around 25% of human breast cancers.
Despite recent advances in HER2 targeted therapy, many patients still experience primary …
Despite recent advances in HER2 targeted therapy, many patients still experience primary …
Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
A Stanley, GH Ashrafi, AM Seddon… - Scientific …, 2017 - pubmed.ncbi.nlm.nih.gov
Overexpression of HER2 has been reported in around 25% of human breast cancers.
Despite recent advances in HER2 targeted therapy, many patients still experience primary …
Despite recent advances in HER2 targeted therapy, many patients still experience primary …
Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
A Stanley, GH Ashrafi, AM Seddon… - Scientific …, 2017 - ui.adsabs.harvard.edu
Overexpression of HER2 has been reported in around 25% of human breast cancers.
Despite recent advances in HER2 targeted therapy, many patients still experience primary …
Despite recent advances in HER2 targeted therapy, many patients still experience primary …
[PDF][PDF] Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
A Stanley, GH Ashrafi, AM Seddon… - Scientific …, 2017 - eprints.kingston.ac.uk
Results HER2 is overexpressed in BT474, SKBr3 and MDA-MB-453 while EGFR is
overexpressed in MDA-MB-468. Using flow cytometry, we determined the membrane …
overexpressed in MDA-MB-468. Using flow cytometry, we determined the membrane …
Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
A Stanley, GH Ashrafi, AM Seddon, H Modjtahedi - Scientific Reports, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Overexpression of HER2 has been reported in
around 25% of human breast cancers. Despite recent advances in HER2 targeted therapy …
around 25% of human breast cancers. Despite recent advances in HER2 targeted therapy …
[PDF][PDF] Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
A Stanley, GH Ashrafi, AM Seddon, H Modjtahedi - core.ac.uk
Results HER2 is overexpressed in BT474, SKBr3 and MDA-MB-453 while EGFR is
overexpressed in MDA-MB-468. Using flow cytometry, we determined the membrane …
overexpressed in MDA-MB-468. Using flow cytometry, we determined the membrane …
[HTML][HTML] Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
A Stanley, GH Ashrafi, AM Seddon… - Scientific Reports, 2017 - ncbi.nlm.nih.gov
Overexpression of HER2 has been reported in around 25% of human breast cancers.
Despite recent advances in HER2 targeted therapy, many patients still experience primary …
Despite recent advances in HER2 targeted therapy, many patients still experience primary …
[PDF][PDF] Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
A Stanley, GH Ashrafi, AM Seddon… - Scientific …, 2017 - eprints.kingston.ac.uk
Results HER2 is overexpressed in BT474, SKBr3 and MDA-MB-453 while EGFR is
overexpressed in MDA-MB-468. Using flow cytometry, we determined the membrane …
overexpressed in MDA-MB-468. Using flow cytometry, we determined the membrane …